Onconova Therapeutics Inc. ’s (ONTX) share price has entered into oversold territory with an RSI value of 19.3. The Zacks Consensus Estimate for Onconova for the full year period has improved 75 cents over the past two months to $-2.09 per share. Currently, Onconova has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get in on (ONTX) after its recent drop.
ONCONOVA THERAPEUTICS INC (ONTX): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading